FDA Adverse Event Injury Summary report: N

COULTER LH 500 ANALYZER

MDR report key: 1912102 · Received December 1, 2010

Report

Report Number
1061932-2010-00240
Event Type
Injury
Date Received
December 1, 2010
Date of Event
October 30, 2010
Report Date
November 2, 2010
Manufacturer
BECKMAN COULTER INC.
Product Code
LOQ
PMA / PMN Number
K032000
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

PRE AND POST TRANSFUSION PATIENT SAMPLES WERE OBTAINED BY VENIPUNCTURE AND COLLECTED IN 5.0ML EDTA TUBES. SAMPLES WERE FRESH AND PROCESSED IN THE AUTOMATIC SAMPLING MODE. CONTROLS ARE RUN THREE TIMES DAILY AND WERE RUN APPROXIMATELY 5 HOURS PRIOR TO THE INCIDENT AND WERE WITHIN THE ASSAY LIMITS. A FIELD SERVICE ENGINEER (FSE) WENT ON-SITE AND SERVICED THE INSTRUMENT BY REPLACING SOME HARDWARE AND PERFORMED ADJUSTMENTS AND REPAIRS AS NEEDED. FSE RESTORED PROPER SAMPLE ASPIRATION AND VERIFIED THE SYSTEM'S OPERATION. THE ROOT CAUSE IS UNKNOWN. HOWEVER, THE SYSTEM PROVIDED INSTRUMENT GENERATED PARTIAL ASPIRATION (P) FLAGS TO ALERT THE OPERATOR TO REVIEW THE INSTRUMENT RESULTS.

Description of Event or Problem · 1

A CUSTOMER CONTACTED BECKMAN COULTER INC. (BCI) REGARDING ERRONEOUS CBC RESULTS GENERATED BY THE COULTER LH 500 ANALYZER WITH INSTRUMENT GENERATED PARTIAL ASPIRATION (P) FLAGS FOR A PATIENT SAMPLE. THE ERRONEOUS RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY AND THE PATIENT WAS TRANSFUSED WITH TWO UNITS OF BLOOD BASED ON THE ERRONEOUS LOW HEMOGLOBIN (HGB) RESULTS. A NEW PATIENT SAMPLE WAS OBTAINED 1 HOUR POST TRANSFUSION AND CBC ANALYSIS WAS PERFORMED. THE PHYSICIAN QUESTIONED THE INCREASED HGB RESULT AND CONCLUDED THAT THE PRE-TRANSFUSION HGB RESULT WAS INCORRECT. THE ORIGINAL RESULT WAS AMENDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 COULTER LH 500 ANALYZER AUTOMATED DIFFERENTIAL CELL COUNTER LOQ BECKMAN COULTER INC. LH 500 NA

Patients

Seq Age Sex Outcome Treatment
1 Other